Apobiologix

Overview
Biosimilars?
Product stageSegments
Growth
?
Pure Play Biosimilars Developers
?

Apobiologix is a division of Apotex Inc., Canada's largest pharmaceutical company, focused on developing and producing biosimilar medicines. As part of the Apotex Group of Companies, Apobiologix benefits from Apotex's global reach, with sales in over 115 countries worldwide. The company is committed to transforming access to affordable biologic medicines in Canada. Apobiologix operates within Apotex's integrated portfolio, which includes generic, biosimilar, and innovative branded pharmaceutical products for global markets.

Apobiologix offers a patient support program called the Answers Program, which provides comprehensive assistance to patients using their biosimilar products. The company also runs the Apobiologix Partnership Program (APP), an initiative focused on supporting partners with various projects and programs. As of April 2024, Apotex employed almost 7,000 people worldwide in manufacturing, R&D, and commercial operations, with its medicines accessible to patients in more than 75 countries globally.

Key customers and partnerships

Apobiologix, as part of Apotex Inc., serves healthcare professionals and patients across Canada and internationally. In February 2024, Apotex entered into an exclusive out-licensing agreement with Harrow, Inc. for five branded ophthalmic pharmaceutical products in the Canadian market. This partnership allows Apotex to market and distribute VERKAZIA and over-the-counter Cationorm PLUS in Canada, while also pursuing market approval for VEVYE, IHEEZO, and ZERVIATE. This alliance expands Apotex's product offering in Canada to include innovative patented pharmaceutical medicines, aligning with its strategic focus on expanding into innovative branded pharmaceutical therapeutic areas.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
4100 Weston Rd Toronto ON CAN
Founded year:
2007
Employees:
101-250
IPO status:
Private
Total funding:
-
Last Funding:
-
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.